119 related articles for article (PubMed ID: 1241500)
1. [Complications in chloroquin therapy].
Siegmeth W
Acta Med Austriaca; 1975; 2(4):116-21. PubMed ID: 1241500
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
Aylward JM
J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
[TBL] [Abstract][Full Text] [Related]
3. [Chloroquine and hydroxychloroquine: side effect profile of important therapeutic drugs].
Ochsendorf FR; Runne U
Hautarzt; 1991 Mar; 42(3):140-6. PubMed ID: 2055762
[TBL] [Abstract][Full Text] [Related]
4. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
Leecharoen S; Wangkaew S; Louthrenoo W
J Med Assoc Thai; 2007 Jan; 90(1):52-8. PubMed ID: 17621733
[TBL] [Abstract][Full Text] [Related]
5. Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study.
Kobak S; Deveci H
Int J Rheum Dis; 2010 Aug; 13(3):e11-5. PubMed ID: 20704603
[TBL] [Abstract][Full Text] [Related]
6. [Chloroquine retinopathy. Peculiar behavior of the light sense].
Stein R; Godel V; Nemet P
Klin Monbl Augenheilkd; 1972 Aug; 161(2):183-91. PubMed ID: 4638561
[No Abstract] [Full Text] [Related]
7. Antimalarial therapy in SLE.
Lanham JG; Hughes GR
Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
[No Abstract] [Full Text] [Related]
8. Keratopathy with low dose chloroquine therapy.
Cullen AP; Chou BR
J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
[TBL] [Abstract][Full Text] [Related]
9. [The therapy of systemic lupus erythematosus].
Ochsendorf FR; Runne U
Dtsch Med Wochenschr; 1997 Jul; 122(27):877. PubMed ID: 9280702
[No Abstract] [Full Text] [Related]
10. [Complications with synthetic antimalarials].
Huriez C; Desmons F; Gautier G; Dhellemmes
Lille Med; 1969 Oct; 14(8):851-64. PubMed ID: 4251585
[No Abstract] [Full Text] [Related]
11. [Current view on chloroquine derivative treatment from rheumatologist perspective and possible ocular side effects].
Pawlak-Buś K; Gaca-Wysocka M; Grzybowski A; Leszczyński P
Pol Merkur Lekarski; 2016 Mar; 40(237):202-6. PubMed ID: 27088206
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.
Tang C; Godfrey T; Stawell R; Nikpour M
Intern Med J; 2012 Sep; 42(9):968-78. PubMed ID: 22827853
[TBL] [Abstract][Full Text] [Related]
13. Delayed onset chloroquine retinopathy: case report.
Martin LJ; Bergen RL; Dobrow HR
Ann Ophthalmol; 1978 Jun; 10(6):723-6. PubMed ID: 677653
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of antimalarials in systemic lupus erythematosus.
Rudnicki RD; Gresham GE; Rothfield NF
J Rheumatol; 1975 Sep; 2(3):323-30. PubMed ID: 1102684
[TBL] [Abstract][Full Text] [Related]
15. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1966; 44(3):335-48. PubMed ID: 5953229
[No Abstract] [Full Text] [Related]
16. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
[No Abstract] [Full Text] [Related]
17. The use of Amsler grids in early chloroquine retinopathy.
Easterbrook M
Ophthalmology; 1984 Nov; 91(11):1368-72. PubMed ID: 6514305
[TBL] [Abstract][Full Text] [Related]
18. The connective tissue diseases and the overall influence of gender.
Lahita RG
Int J Fertil Menopausal Stud; 1996; 41(2):156-65. PubMed ID: 8829695
[TBL] [Abstract][Full Text] [Related]
19. [2 cases of neuromyopathy induced by antimalarials (retrospective diagnosis)].
Panahi F; Braun S; Guiraudon C; Delbarre F
Bull Mem Soc Med Hop Paris; 1968 Feb 9-16; 119(3):223-39. PubMed ID: 5703989
[No Abstract] [Full Text] [Related]
20. The blood-retinal barrier in chloroquine retinopathy.
Raines MF; Bhargava SK; Rosen ES
Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1726-31. PubMed ID: 2759787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
